Items Tagged ‘biotech’

September 6, 2019

Mayo Clinic in the News Weekly Highlights for September 6, 2019

By Emily Blahnik eblahnik

NBC, Signs of a deadly mosquito virus found in several states by Erika Edwards — … Infectious disease specialists have their eyes on mosquitoes that are transmitting diseases in other parts of the world, too, such as yellow fever and the Mayaro virus in South America, dengue in Asia and Rift Valley fever in Africa. […]

View full entry

Tags: ADHD, Affordable care act, aging, AI, artificial Intelligence, asthma, back pain, back to school, Battle of the Badges, biotech, bullying, burnout


May 12, 2017

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich KarlWOestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Editor, Karl Oestreich;  Assistant Editor: Emily Blahnik   BBC News From Cotton Picker to Brain Surgeon Dr Alfredo Quinones-Hinojosa […]

View full entry

Tags: 3D printing, A.L.S., AACC, ABC 6 Philadelphia, Abdereen News, AccuWeather, ADHD, Ambient Clinical Analytics, AOL, Arizona Republic, AZ Big Media, Banner Health


October 11, 2012

Elk Run Biotech Campus May Get First Business

By Kelley Luckstein KelleyLuckstein

Elk Run, the long-awaited campus for biotech firms between the Twin Cities and Rochester, might finally be showing signs of life. Tower Investments officials confirmed Wednesday that they’ve asked for plat map changes to accommodate construction of a 200,000-square-foot building to house a biotech firm seeking to expand. The building would be constructed in phases, […]

View full entry

Tags: biotech, Elk Run, John Pierce, Star Tribune, Tower Investments


December 9, 2009

Mayo Clinic linked biotech plans estimated $74M IPO

By Kelley Luckstein KelleyLuckstein

A Belgium biotech company that licenses Mayo Clinic research and is partially owned by Mayo – Cardio3 BioSciences Cardio3 BioSciences is licensing Mayo Clinic research about “differentiating” stem cells, or turning generic stem cells from bone marrow into cardiac cells.    Post-Bulletin, by Jeff Kiger, 12/8/09

View full entry

Tags: biotech, Cardio3 BioSciences


Contact Us · Privacy Policy